Observational Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Feb 7, 2016; 22(5): 1877-1883
Published online Feb 7, 2016. doi: 10.3748/wjg.v22.i5.1877
Table 4 Detailed endoscopic findings in 51 patients presenting with gastrointestinal bleeding after non-steroidal anti-inflammatory drug use n (%)
Variables3 yr(n = 11)> 37 yr(n = 14)> 716 yr(n = 26)P value
Upper GI lesions0.04
Proximal (esophagus and stomach)10 (100)12 (85.7)15 (62.5)
Distal (duodenum)02 (14.3)9 (37.5)
Location0.06
Esophagus2 (18.1)2 (14.3)4 (15.4)
Stomach8 (72.7)10 (71.4)11 (42.3)
Duodenum02 (14.3)9 (34.6)
Colon1 (9)01 (3.8)
Esophagus0.90
Upper000
Middle000
Lower2 (18.1)2 (14.3)4 (15.3)
Los Angeles classification0.50
Grade A2 (100)2 (100)3 (75)
Grade B001 (25)
Grade C000
Grade D000
Stomach0.09
Antrum004 (36.4)
Body4 (50)4 (40)3 (27.3)
Fundus4 (50)6 (60)4 (36.4)
Type of lesions0.40
Erythema5 (62.5)8 (80)4 (36.4)
Edema01 (10)1 (9.1)
Erosions2 (25)1 (10)3 (27.3)
Ulcerations1 (12.5)03 (27.3)
Duodenum1.00
Bulb02 (100)8 (88.9)
Duodenum001 (11.1)
Type of lesions0.02
Nodularity01 (50)1 (11.1)
Erythema01 (50)0
Erosions000
Ulcerations008 (88.8)
Forrest Classification for ulcerations0.30
Grade 1a002 (18.2)
Grade 1b001 (9.1)
Grade 2a1 (100)02 (18.2)
Grade 2b000
Grade 2c002 (15.4)
Grade 3006 (54.5)
Colon
Transverse1 (9)00
Sigmoid001 (3.8)
Type of lesions
Erythema1 (100)00
Edema001 (100)